Portfolio (Quarterly)
Guide ↗
E Fund Management Co., Ltd.
· CIK 0001842296| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | T | AT&T INC | Communication Services | 26,185.0 | $759K | 0.02% | -49K | -65.0% | $28.99 | -14.9% |
| 42 | ZS | ZSCALER INC | Technology | 5,132.0 | $720K | 0.02% | -10K | -66.1% | $140.29 | +8.1% |
| 43 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 1,347.0 | $705K | 0.02% | -1K | -50.8% | $523.47 | +2.9% |
| 44 | TGTX | TG THERAPEUTICS INC | Healthcare | 20,706.0 | $688K | 0.02% | -303.0 | -1.4% | $33.22 | +65.2% |
| 45 | ON | ON SEMICONDUCTOR CORP | Technology | 11,005.0 | $681K | 0.02% | -20K | -64.3% | $61.92 | +36.3% |
| 46 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 6,033.0 | $636K | 0.02% | -3K | -32.9% | $105.40 | +29.8% |
| 47 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 1,071.0 | $635K | 0.02% | -3K | -72.4% | $592.98 | -11.7% |
| 48 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 10,000.0 | $627K | 0.02% | -6K | -36.7% | $62.70 | +36.8% |
| 49 | DIS | DISNEY WALT CO | Communication Services | 6,499.0 | $626K | 0.02% | -12K | -65.4% | $96.38 | +2.6% |
| 50 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 8,162.0 | $606K | 0.02% | -14K | -62.8% | $74.26 | +15.2% |
| 51 | PTCT | PTC THERAPEUTICS INC | Healthcare | 8,863.0 | $604K | 0.02% | -2K | -18.7% | $68.13 | +10.7% |
| 52 | CYTK | CYTOKINETICS INC | Healthcare | 9,150.0 | $603K | 0.02% | -10K | -51.6% | $65.91 | +20.5% |
| 53 | EXEL | EXELIXIS INC | Healthcare | 13,928.0 | $597K | 0.02% | -12K | -46.2% | $42.89 | +31.8% |
| 54 | CGON | CG ONCOLOGY INC | Healthcare | 8,779.0 | $594K | 0.02% | -153.0 | -1.7% | $67.68 | +7.3% |
| 55 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 4,489.0 | $591K | 0.02% | -4K | -48.1% | $131.74 | +38.8% |
| 56 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 2,281.0 | $589K | 0.02% | -2K | -41.1% | $258.32 | +41.0% |
| 57 | PCVX | VAXCYTE INC | Healthcare | 10,099.0 | $587K | 0.02% | -8K | -45.1% | $58.11 | -6.0% |
| 58 | FOLD | AMICUS THERAPEUTIC | Healthcare | 40,461.0 | $585K | 0.02% | -6K | -12.7% | $14.46 | +0.2% |
| 59 | ACLX | ARCELLX INC | Healthcare | 5,084.0 | $584K | 0.02% | -1K | -19.2% | $114.82 | +0.2% |
| 60 | NTRA | NATERA INC | Healthcare | 2,884.0 | $577K | 0.02% | -4K | -55.2% | $199.99 | +26.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
53.1%
Consumer Cyclical
19.5%
Communication Services
8.9%
Financial Services
5.9%
Healthcare
4.6%
Consumer Defensive
2.9%
Industrials
2.5%
Basic Materials
1.0%
Utilities
0.8%
Energy
0.7%